How Minnesota's Prescription Drug Affordability Board affects patient access: statute, board actions, Minnesota PDAB Back to PDAB Policy Center Information, updates, and engagement opportunities related number=SF2744&version=latest&session=ls93&session_year=2023&session_number=0 Note: For the Minnesota Public Comments Letters and testimony submitted regarding state PDAB activity CANN Public Comment: Minnesota PDAB Affordability Examination Publication date: 8/6/25 Comment on Minnesota PDAB's affordability examination

Patient-centered tracking of 340B policy in Minnesota: active bills, committee assignments, fact sheets Minnesota 340B Watch Stay informed on state-level actions, proposed legislation, and advocacy efforts Contact Us News 340B Misuse In Minnesota The February 2026 Minnesota Department of Health 340B Covered Comments Letters, testimony, and press releases submitted regarding state 340B activity CANN Statement on Minnesota View PDF Current Legislative Session Activity in Minnesota No legislative activity in the 2026 session

share hospitals earn more in estimated 340B profit than they spend on charity care. 340B Misuse In Minnesota The February 2026 Minnesota Department of Health 340B Covered Entity Report found that less than 1% Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota

and calling for a clearer patient definition and child site language. 07/06/2026 CANN Statement on Minnesota Department of Health 340B Covered Entity Report (June 2026) Jen Laws responds to Minnesota's February for a clearer patient definition and child site language. 07/06/2026 Press Release CANN Statement on Minnesota Department of Health 340B Covered Entity Report (June 2026) Jen Laws responds to Minnesota's February

Colorado Maryland New Jersey Connecticut Massachusetts Ohio Illinois Michigan Oregon Iowa Minnesota Vermont